AI-GF-GNW on Prolonged Grief Reactions
AI-Assisted Grief-Focused Guided Narrative Writing for Subclinical Prolonged Grief Disorder in Bereaved Chinese Adolescents: A Three-Arm Parallel Randomized Controlled Trial.
Prolonged Grief Disorder (PGD) is a severe, disabling condition characterized by intense yearning and difficulty accepting the reality of loss, which significantly impairs the academic and psychosocial functioning of bereaved adolescents. While Grief-Focused Cognitive Behavioral Therapy (GF-CBT) is effective, its high cost and resource-intensive nature limit its accessibility for adolescents in mainland China. Grief-Focused Guided Narrative Writing (GF-GNW) offers a scalable, low-cost alternative that facilitates memory integration.
Furthermore, integrating Artificial Intelligence (AI) to provide personalized, structured feedback has the potential to simulate therapist functions and enhance intervention efficacy. However, the specific efficacy of AI-assisted feedback in this context remains empirically unvalidated.
This parallel randomized controlled trial aims to examine the effectiveness of AI-assisted GF-GNW (AI-GF-GNW) in treating Chinese adolescents (aged 10-19) with subclinical PGD, compared to a no-feedback NF-GF-GNW group and a free writing group. Primary outcomes include PGD symptom severity, while secondary outcomes assess depression, anxiety, and daily functioning. We hypothesize that both active intervention arms will significantly alleviate PGD and related symptoms compared to the free writing group, and that the AI-GF-GNW group will demonstrate a significantly greater reduction in symptoms and functional impairment than the NF-GF-GNW group.
연구 개요
상태
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Yinyin Zang, PhD
- 전화번호: +86-010-62756953
- 이메일: yinyin.zang@pku.edu.cn
연구 장소
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, 중국
- Peking University
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 어린이
- 성인
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Junior and senior high school students currently studying in Chinese Mainland, aged 10-19;
- Between 6 and 60 months prior to the experimental period, experienced the death of a significant family member or close friend or close friend;
- The total symptom score of PG-13-R is between 20-29 points;
- Ability to write and understand written guidelines, to use the mobile phone to interact with AI;
- Consent to participate in the study.
Exclusion Criteria:
- Diagnosed or previously diagnosed with mental illness
- The bereavement time does not meet the time window
- PG-13-R score is not within the range
- At present, there is suicidal ideation or recent severe self harm behavior (Reynolds' Suicidal Ideation Questionnaire, SIQ-JR-4>0), and a crisis intervention hotline is provided when necessary.
- Has received other grief counseling or is currently taking psychiatric medication within the past month
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: AI-GF-GNW
|
Participants will independently complete the intervention writing tasks via the H5 platform.
Participants were required to complete a 6-day, 3-session narrative writing task.
Each session requires more than 20 minutes of uninterrupted writing.
Session 1 requires describing the specific details and feelings of the bereavement event; Session 2 requires describing the negative impact of the event and one's own negative feelings; Session 3 requires a description of the positive impact of the event and one's own positive feelings, with a one-day interval between each session, synchronized with the NF-GF-GNW group.
When participants complete and submit their writing, they will immediately receive a response generated by the AI large language model.
Participants are not allowed to engage in any additional interaction with the AI large language model other than submitting writing content and receiving feedback.
|
|
실험적: NF-GF-GNW
|
All processes are the same as the AI-GF-GNW group, except that when participants complete their writing and submit, the platform will only display a "submission successful" prompt and will not provide any feedback on the writing content.
|
|
활성 비교기: FWG
|
Participants in the FWG will not receive structured guidance, and are only required to write freely about their loss experiences.
The writing sessions will follow the same schedule and duration as the other groups.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Prolonged Grief Disorder-13-Revision (PG-13-R)
기간: Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
PG-13-R is a standardized diagnostic tool designed to assess the severity of prolonged grief disorder symptoms over the past month.
The instrument consists of 10 questions scored on a 5-point Likert scale, alongside 2 true/false questions and 1 open-ended question assessing functional impairment and duration.Who gets 30 points or higher will be considered as clinical prolonged grief reactions.
|
Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
|
Patient Health Questionnaire (PHQ-9)
기간: Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
PHQ-9 is a brief, validated screening tool used to measure the severity of depression symptoms in adolescents over the past two weeks.
9 questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.
|
Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Generalized Anxiety Disorder (GAD-7)
기간: Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
GAD-7 is an easy-to-perform initial screening tool for generalized anxiety disorder.
Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.
|
Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
|
WHO Disability Assessment Schedule-short version(WHODAS 2.0)
기간: Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
WHODAS 2.0 is a comprehensive instrument developed by the World Health Organization to measure health status and functional disability across six core domains over the past 30 days.
12 questions are scored on a Likert scale of 1-5 with 1 being no difficulty and 5 being extreme difficulty.
|
Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .